ARIDIS PHARMACEUTICAL (ARDS) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 41 148 sessions, October 23, 2025 to October 23, 2026
- Largest daily move
- +1300% close of February 3, 2026
- 1-year change
- -86.7% closing prices, October 23, 2025 to October 23, 2026
- 1-month change
- +100% closing prices, September 22, 2026 to October 23, 2026
Company Description
ARIDIS PHARMACEUTICAL (OTC: ARDS) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $8.9K.
ARDS has declined 86.7% over the past year. The last closing price was $0.0002.
For FY2022, ARIDIS PHARMACEUTICAL reported revenue of $3.1M with net income of -$30.4M.
This page collects what Stock Titan holds for ARDS, including price data, latest news, SEC filings, financial highlights, and short interest trends.
Stock Performance
ARIDIS PHARMACEUTICAL (ARDS) closed at $0.0002 on October 23, 2026. Over the past 12 months, the price has lost 86.7%.
ARDS Metrics & Rankings
Price returns through October 23, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
ARIDIS PHARMACEUTICAL has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, clinical trial, fda approval. View all ARDS news →
SEC Filings
ARIDIS PHARMACEUTICAL has filed 3 recent SEC filings, including 3 Form SCHEDULE 13G/A. The most recent filing was submitted on August 14, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ARDS SEC filings →
Financial Highlights
ARIDIS PHARMACEUTICAL generated $3.1M in revenue in FY2022, operating income reached -$30.0M, and net income was -$30.4M. The company generated -$29.1M in operating cash flow. The current ratio was 0.32, measuring current assets divided by current liabilities.
Upcoming Events
Short Interest History
Short interest in ARIDIS PHARMACEUTICAL (ARDS) currently stands at 15.7 thousand shares, down 0.1% from the previous reporting period, representing 0.0% of the float. Since October 2025, short interest has decreased by 39.0%.
Days to Cover History
Days to cover for ARIDIS PHARMACEUTICAL (ARDS) currently stands at 1.9 days, down 72.2% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 18.2 days.
ARDS Company Profile & Sector Positioning
ARIDIS PHARMACEUTICAL (ARDS) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing ARDS often look at related companies in the same sector, including SYROS PHARMACEUTICALS INC (SYRS), NAVIDEA BIOPHARMS INC (NAVB), TRACON PHARMS INC (TCON), PAXMEDICA INC (PXMD), and NDONOVO THERAPEUTICS INC (ENDV). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate ARDS's relative position within its industry.